(1,3)-Béta-D-Glucan Levels at Diagnosis of Juvenile Idiopathic Arthritis and Its Correlation With Activity's Disease : a Cohort Sudy

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 11, 2019

Primary Completion Date

June 1, 2020

Study Completion Date

June 1, 2020

Conditions
Juvenile Idiopathic Arthritis
Interventions
DIAGNOSTIC_TEST

The Juvenile Disease Activity Score (JADAS)

The JADAS includes the following four measures: physician's global assessment of disease activity, measured on a 0-10 visual analog scale (VAS) where 0 = no activity and 10 = maximum activity; parent global assessment of well-being, measured on a 0-10 VAS where 0 = very well and 10 = very poor; the erythrocyte sedimentation rate (ESR), normalized to a 0 to 10 scale; and a count of joints with active disease.

BIOLOGICAL

(1-3)-ß-D-Glucan (BDG) assay (Fungitell)

Evaluation of the (1,3)-Beta-D-Glucans level in patients with JIA and correlation of the higher serum BDG levels with JIA activity of disease, comparatively with usual markers

Trial Locations (1)

80054

CHU Amiens, Amiens

All Listed Sponsors
lead

Centre Hospitalier Universitaire, Amiens

OTHER

NCT03984669 - (1,3)-Béta-D-Glucan Levels at Diagnosis of Juvenile Idiopathic Arthritis and Its Correlation With Activity's Disease : a Cohort Sudy | Biotech Hunter | Biotech Hunter